Biohaven Pharmaceutical Holding Company Ltd. Stock
Biohaven Pharmaceutical Holding Company Ltd. Stock price
Key metrics
| Market capitalization | $3.72b |
| Enterprise Value | $3.32b |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 9.48 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-781.27m |
| Free Cash Flow (TTM) Free Cash Flow | $-485.24m |
| Cash position | $437.10m |
Is Biohaven Pharmaceutical Holding Company Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.
Biohaven Pharmaceutical Holding Company Ltd. Stock Analysis
Analyst Opinions
13 Analysts have issued a Biohaven Pharmaceutical Holding Company Ltd. forecast:
Analyst Opinions
13 Analysts have issued a Biohaven Pharmaceutical Holding Company Ltd. forecast:
Financial data from Biohaven Pharmaceutical Holding Company Ltd.
| Jun '24 |
+/-
%
|
||
| Net Profit | -320 -320 |
254%
254%
|
|
| Depreciation and Amortization | 0.98 0.98 |
23%
23%
|
|
| Stock Compensation | 12 12 |
160%
160%
|
|
| Operating Cash Flow | -168 -168 |
278%
278%
|
|
| Investments | 2.95 2.95 |
392%
392%
|
|
| Dividend Paid | - - |
-
|
|
| Free Cash Flow | -171 -171 |
280%
280%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Biohaven Pharmaceutical Holding Company Ltd. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Biohaven Pharmaceutical Holding Company Ltd. Stock News
Company Profile
Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.
| Head office | Virgin Islands, British |
| CEO | Vladimir Coric |
| Employees | 239 |
| Founded | 2022 |
| Website | www.biohaven.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
